04:30:35 EDT Fri 09 May 2025
Enter Symbol
or Name
USA
CA



Onco-Innovations Ltd
Symbol ONCO
Shares Issued 47,153,310
Close 2025-03-25 C$ 1.79
Market Cap C$ 84,404,425
Recent Sedar Documents

Onco-Innovations extends marketing program with MCS

2025-03-25 19:13 ET - News Release

Mr. Thomas O'Shaughnessy reports

ONCO-INNOVATIONS EXTENDS MARKETING PROGRAM

Onco-Innovations Ltd. has extended the term of its engagement with MCS Market Communication Service GmbH (business address: Rheinpromenade 13, 40789 Monheim am Rhein, Nordrhein-Westfalen, Deutschland, e-mail: info@mcsmarket.de; telephone: 491772481220) for the continued provision of a range of on-line marketing services, including campaign creation, production of marketing materials, as well as research and analytics. The services are expected to run until May 31, 2025, or until budget exhaustion. The company has paid MCS $600,000 for the extended term of services, and no securities have been provided to MCS or its principals as compensation. The services will be executed via digital channels, including Google ads and native advertising.

About Onco-Innovations Ltd.

Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. The company's mission is to prevent and cure cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide licence to patented technology that targets solid tumours, setting new standards in cancer treatment. Onco-Innovations' commitment to excellence and innovation drives it to develop advanced therapies that improve patient outcomes and offer hope in the fight against cancer.

We seek Safe Harbor.

© 2025 Canjex Publishing Ltd. All rights reserved.